Equities Analysts Issue Forecasts for SurgePays Q4 Earnings

SurgePays, Inc. (NASDAQ:SURG) – Research analysts at Sidoti Csr dropped their Q4 2025 EPS estimates for SurgePays in a research note issued to investors on Wednesday, March 26th. Sidoti Csr analyst A. Soderstrom now anticipates that the medical equipment provider will post earnings of $0.06 per share for the quarter, down from their prior forecast of $0.11. The consensus estimate for SurgePays’ current full-year earnings is ($1.66) per share. Sidoti Csr also issued estimates for SurgePays’ Q1 2026 earnings at $0.19 EPS.

SurgePays (NASDAQ:SURG) last released its quarterly earnings results on Tuesday, March 25th. The medical equipment provider reported ($0.93) EPS for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.66). SurgePays had a negative return on equity of 55.63% and a negative net margin of 27.39%. The company had revenue of $9.59 million for the quarter, compared to the consensus estimate of $8.22 million.

Separately, Ascendiant Capital Markets reduced their target price on SurgePays from $9.00 to $8.50 and set a “buy” rating for the company in a report on Monday, December 16th.

SurgePays Trading Down 7.2 %

Shares of SurgePays stock opened at $2.18 on Thursday. The business has a fifty day simple moving average of $1.41 and a 200-day simple moving average of $1.62. The firm has a market cap of $43.95 million, a price-to-earnings ratio of -1.93 and a beta of 1.03. SurgePays has a fifty-two week low of $1.05 and a fifty-two week high of $4.38. The company has a quick ratio of 4.70, a current ratio of 6.24 and a debt-to-equity ratio of 0.08.

Institutional Trading of SurgePays

Hedge funds and other institutional investors have recently modified their holdings of the business. Truvestments Capital LLC boosted its position in SurgePays by 23.1% during the 3rd quarter. Truvestments Capital LLC now owns 84,946 shares of the medical equipment provider’s stock worth $156,000 after acquiring an additional 15,956 shares during the period. Corsair Capital Management L.P. boosted its holdings in shares of SurgePays by 50.3% during the third quarter. Corsair Capital Management L.P. now owns 29,864 shares of the medical equipment provider’s stock worth $55,000 after purchasing an additional 10,000 shares during the period. Geode Capital Management LLC grew its position in SurgePays by 11.3% during the third quarter. Geode Capital Management LLC now owns 148,018 shares of the medical equipment provider’s stock valued at $272,000 after purchasing an additional 15,039 shares in the last quarter. Virtu Financial LLC acquired a new position in SurgePays in the 3rd quarter valued at approximately $25,000. Finally, Renaissance Technologies LLC lifted its position in SurgePays by 43.6% in the 4th quarter. Renaissance Technologies LLC now owns 49,400 shares of the medical equipment provider’s stock worth $88,000 after buying an additional 15,000 shares in the last quarter. Institutional investors and hedge funds own 6.94% of the company’s stock.

SurgePays Company Profile

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.